Breast Carcinoma — Trials

Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,394 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 873
Recruiting: 477
Ph III recruiting: 54
Growth YoY: 0%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07768358	Tucatinib Continuation Study	not yet recruiting	Phase 4	175	PfizerINDUSTRY	0	Aug 28, 2026	clinicaltrials
NCT07589699	Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP	not yet recruiting	Phase 4	59	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	0	May 15, 2026	clinicaltrials